K Njoku, CE Barr, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Endometrial cancer is the most common gynaecological malignancy in high income countries and its incidence is rising. Whilst most women with endometrial cancer are …
This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on …
E Kalampokas, G Giannis, T Kalampokas… - Cancers, 2022 - mdpi.com
Simple Summary New data, the development of new methods of treatment and management and the rising incidence of endometrial cancer require constant reviewing, in order to inform …
Simple Summary The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway controls the induction and maintenance of immune tolerance …
K Njoku, CE Barr, NC Ramchander, EJ Crosbie - PloS one, 2022 - journals.plos.org
Purpose The Onodera's prognostic nutritional index (PNI) and the haemoglobin, albumin, lymphocyte and platelet (HALP) score are immune-nutritional indices that correlate with …
The landscape of diagnosing and treating endometrial cancer is undergoing a profound transformation due to the integration of molecular analysis and innovative therapeutic …
HJ Agnew, SJ Kitson, EJ Crosbie - Best Practice & Research Clinical …, 2023 - Elsevier
The global pandemic of obesity has had a significant impact on gynecological malignancies, most notably endometrial cancer. It has resulted in worldwide increases in the incidence of …
K Njoku, A Pierce, B Geary, AE Campbell… - British journal of …, 2023 - nature.com
Background A non-invasive endometrial cancer detection tool that can accurately triage symptomatic women for definitive testing would improve patient care. Urine is an attractive …
K Njoku, HJ Agnew, EJ Crosbie - Frontiers in Oncology, 2022 - frontiersin.org
Purpose Type 2 diabetes mellitus (T2DM) is an established risk factor for endometrial cancer but its impact on endometrial cancer survival outcomes is unclear. The aim of this study was …